Feasibility and Utility of a Flexible Outcome Assessment Battery for Longitudinal Traumatic Brain Injury Research: A TRACK-TBI Study.
assessment
feasibility
outcome assessment
traumatic brain injury
Journal
Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
pmc-release:
01
02
2024
pubmed:
14
9
2022
medline:
4
2
2023
entrez:
13
9
2022
Statut:
ppublish
Résumé
The effects of traumatic brain injury (TBI) are difficult to measure in longitudinal cohort studies, because disparate pre-injury characteristics and injury mechanisms produce variable impairment profiles and recovery trajectories. In preparation for the Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study, which followed patients with injuries ranging from uncomplicated mild TBI to coma, we designed a multi-dimensional Flexible outcome Assessment Battery (FAB). The FAB relies on a decision-making algorithm that assigns participants to a Comprehensive (CAB) or Abbreviated Assessment Battery (AAB) and guides test selection across all phases of recovery. To assess feasibility of the FAB, we calculated the proportion of participants followed at 2 weeks (2w) and at 3, 6, and 12 months (3m, 6m, 12m) post-injury who completed the FAB and received valid scores. We evaluated utility of the FAB by examining differences in 6m and 12m Glasgow Outcome Scale-Extended (GOSE) scores between participant subgroups derived from the FAB-enabled versus traditional approach to outcome assessment applied at 2w. Among participants followed at 2w (
Identifiants
pubmed: 36097759
doi: 10.1089/neu.2022.0141
pmc: PMC9902043
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
337-348Subventions
Organisme : NINDS NIH HHS
ID : U01 NS086090
Pays : United States
Références
J Neurotrauma. 2012 Jan 1;29(1):59-65
pubmed: 21663544
Eur J Phys Rehabil Med. 2019 Feb;55(1):139-140
pubmed: 30376271
J Neurotrauma. 2019 Oct 1;36(19):2743-2752
pubmed: 31062649
J Neurotrauma. 2017 Jun 8;:
pubmed: 28595478
J Neurotrauma. 2012 Jan 1;29(1):32-46
pubmed: 21545277
J Neurotrauma. 2020 Jan 15;37(2):357-365
pubmed: 31502498
J Neurol. 2020 May;267(5):1245-1254
pubmed: 31773246
J Neurotrauma. 1998 Aug;15(8):573-85
pubmed: 9726257
Brain Inj. 2015;29(11):1259-72
pubmed: 26274493
Arch Phys Med Rehabil. 2013 Oct;94(10):1855-60
pubmed: 23732164
Science. 1974 Sep 27;185(4157):1124-31
pubmed: 17835457
Arch Phys Med Rehabil. 2020 Nov;101(11):2041-2050
pubmed: 32738198
Arch Phys Med Rehabil. 2021 Jan;102(1):87-96
pubmed: 33022273
J Neurotrauma. 2019 Apr 1;36(7):1136-1146
pubmed: 30226400
J Neurotrauma. 2021 Apr 15;38(8):1048-1059
pubmed: 33107388
J Neurotrauma. 2013 Nov 15;30(22):1831-44
pubmed: 23815563
J Int Neuropsychol Soc. 2004 Oct;10(6):807-17
pubmed: 15637771
Neurotherapeutics. 2010 Jan;7(1):115-26
pubmed: 20129503
J Neurotrauma. 2013 Nov 15;30(22):1852-61
pubmed: 23725058
J Neurotrauma. 2018 May 15;35(10):1138-1145
pubmed: 29648959
Neurology. 2010 Jul 20;75(3):246-52
pubmed: 20554940
J Neurotrauma. 1998 Sep;15(9):685-92
pubmed: 9753216
Arch Phys Med Rehabil. 2005 May;86(5):896-904
pubmed: 15895334
J Neurotrauma. 2020 Feb 15;37(4):675-679
pubmed: 31663425
JAMA. 2012 Nov 21;308(19):1993-2000
pubmed: 23168823
J Neurotrauma. 2021 Jan 15;38(2):261-271
pubmed: 33023400
J Neurotrauma. 2021 Sep 1;38(17):2435-2446
pubmed: 33740873
J Neurotrauma. 2021 Sep 1;38(17):2419-2434
pubmed: 33832330
J Head Trauma Rehabil. 2018 May/Jun;33(3):147-157
pubmed: 29385010
J Neurotrauma. 2008 Jul;25(7):719-38
pubmed: 18627252
Arch Phys Med Rehabil. 2004 Dec;85(12):2020-9
pubmed: 15605342
J Neurosurg. 1990 Nov;73(5):699-709
pubmed: 2213159
Nat Rev Neurol. 2015 Feb;11(2):71-2
pubmed: 25582447